Search

everythinglearnresearchcommunity

for

Search:↓

All-trans-retinoic acid stops mink hair growth by affecting cell growth and causing cell death.

Minoxidil-loaded hyaluronic acid microneedles can effectively increase hair growth and could be a promising treatment for hair loss.

Canagliflozin helps overcome progestin resistance in certain endometrial cancer cells.

A new AI-driven method shows promise for treating hair loss with a peptide-based drug.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

Using minoxidil for hair growth may cause skin lesions in some people, and taking breaks from nitrate patches for angina might worsen symptoms.

Blocking the CCR5 receptor may be a new way to treat hair loss from alopecia areata.

The new aptamer TAGX-0003 shows promise as an effective treatment for hair loss disorder alopecia areata.

Minoxidil may protect nerves and improve hair quality during paclitaxel treatment.

SM04554 may increase hair growth as a topical treatment for androgenetic alopecia.

Androgen receptor inactivation delays skin cancer onset and reduces incidence in mice, with gender differences in susceptibility.

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

The gene NM_026333 slows down aging by affecting the NCX1 pathway and could be targeted for anti-aging treatments.

Finasteride may improve prostate cancer treatment outcomes.

Compound N4 effectively kills breast cancer cells and compounds N2 and N3 have strong antibacterial and antifungal properties.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

Minoxidil can lower blood pressure effectively and safely in emergencies.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

Blocking 5α-reductase can harm memory and brain structure, and increase harmful brain changes in male mice used for Alzheimer's disease research.

Astressin-B can reverse and prevent hair loss in stressed mice.

TAK-279 effectively reduces psoriasis symptoms and is safe.

New nanocarriers were developed for safer, targeted drug delivery and diagnostics, showing promise for future medical use.

2-DG reduces seizures by enhancing brain inhibition through specific receptor activation.

Metyrapone effectively stabilizes severe Cushing's disease symptoms before surgery.

A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with fewer side effects.

DK peptides can reduce hair loss by inhibiting the 5α-reductase enzyme and have antioxidant effects.